Published in Virology on December 11, 2007
Exosome function: from tumor immunology to pathogen biology. Traffic (2008) 4.50
Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell (2010) 4.33
Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat Rev Mol Cell Biol (2010) 4.29
A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature (2013) 3.55
Influenza virus assembly and budding. Virology (2011) 2.90
The ESCRT complexes. Crit Rev Biochem Mol Biol (2010) 2.23
The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J Virol (2008) 2.12
Microvesicles and viral infection. J Virol (2011) 2.10
Influenza virus morphogenesis and budding. Virus Res (2009) 2.07
The cell biology of rabies virus: using stealth to reach the brain. Nat Rev Microbiol (2010) 1.86
Structural organization of a filamentous influenza A virus. Proc Natl Acad Sci U S A (2010) 1.81
Molecular virology of hepatitis E virus. Virus Res (2011) 1.80
Protein-driven membrane stresses in fusion and fission. Trends Biochem Sci (2010) 1.69
Membrane budding. Cell (2010) 1.65
The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J Virol (2012) 1.64
The Rab11 pathway is required for influenza A virus budding and filament formation. J Virol (2010) 1.55
Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol (2010) 1.44
Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress. PLoS Pathog (2017) 1.41
The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza. Virology (2009) 1.35
Membrane deformation and scission by the HSV-1 nuclear egress complex. Nat Commun (2014) 1.34
Spatial relationships between markers for secretory and endosomal machinery in human cytomegalovirus-infected cells versus those in uninfected cells. J Virol (2011) 1.32
Antiviral activity of innate immune protein ISG15. J Innate Immun (2009) 1.25
Moussa virus: a new member of the Rhabdoviridae family isolated from Culex decens mosquitoes in Côte d'Ivoire. Virus Res (2009) 1.23
Efficient budding of the tacaribe virus matrix protein z requires the nucleoprotein. J Virol (2010) 1.20
In vitro reconstitution of the ordered assembly of the endosomal sorting complex required for transport at membrane-bound HIV-1 Gag clusters. Proc Natl Acad Sci U S A (2012) 1.19
No exit: targeting the budding process to inhibit filovirus replication. Antiviral Res (2008) 1.18
Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol (2009) 1.17
Influenza A: understanding the viral life cycle. Yale J Biol Med (2009) 1.17
Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles. J Virol (2010) 1.12
The z protein of the new world arenavirus tacaribe virus has bona fide budding activity that does not depend on known late domain motifs. J Virol (2009) 1.10
Apical transport of influenza A virus ribonucleoprotein requires Rab11-positive recycling endosome. PLoS One (2011) 1.10
PPEY motif within the rabies virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. J Virol (2008) 1.09
Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol (2009) 1.09
The ESCRT system is required for hepatitis C virus production. PLoS One (2011) 1.08
Role of lipids in virus replication. Cold Spring Harb Perspect Biol (2011) 1.08
Proline-rich regions and motifs in trafficking: from ESCRT interaction to viral exploitation. Traffic (2011) 1.08
Host factors involved in hepatitis B virus maturation, assembly, and egress. Med Microbiol Immunol (2012) 1.06
The YPLGVG sequence of the Nipah virus matrix protein is required for budding. Virol J (2008) 1.05
Association of influenza virus proteins with membrane rafts. Adv Virol (2011) 1.04
Crystallographic and functional analysis of the ESCRT-I /HIV-1 Gag PTAP interaction. Structure (2010) 1.04
Influenza virus A M2 protein generates negative Gaussian membrane curvature necessary for budding and scission. J Am Chem Soc (2013) 1.04
Rescue of HIV-1 release by targeting widely divergent NEDD4-type ubiquitin ligases and isolated catalytic HECT domains to Gag. PLoS Pathog (2010) 1.03
The human respiratory syncytial virus matrix protein is required for maturation of viral filaments. J Virol (2012) 1.03
Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication. J Virol (2011) 0.99
Vacuolar protein sorting pathway contributes to the release of Marburg virus. J Virol (2008) 0.99
Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses. J Virol (2014) 0.99
Culture systems for hepatitis E virus. J Gastroenterol (2012) 0.98
A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus. J Med Chem (2011) 0.98
Studies of an influenza A virus temperature-sensitive mutant identify a late role for NP in the formation of infectious virions. J Virol (2008) 0.97
Electron tomography reveals the steps in filovirus budding. PLoS Pathog (2010) 0.97
Influenza virus budding does not require a functional AAA+ ATPase, VPS4. Virus Res (2010) 0.97
F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding. Proc Natl Acad Sci U S A (2012) 0.96
Exosomes and Their Role in the Life Cycle and Pathogenesis of RNA Viruses. Viruses (2015) 0.95
Subviral particle release determinants of prototype foamy virus. J Virol (2008) 0.95
Viral and host proteins that modulate filovirus budding. Future Virol (2010) 0.93
Characterization of a novel bipartite double-stranded RNA mycovirus conferring hypovirulence in the phytopathogenic fungus Botrytis porri. J Virol (2012) 0.93
Roles played by capsid-dependent induction of membrane curvature and Gag-ESCRT interactions in tetherin recruitment to HIV-1 assembly sites. J Virol (2013) 0.92
Viral membrane scission. Annu Rev Cell Dev Biol (2013) 0.92
Peek-a-boo: membrane hijacking and the pathogenesis of viral hepatitis. Trends Microbiol (2013) 0.92
The SV40 late protein VP4 is a viroporin that forms pores to disrupt membranes for viral release. PLoS Pathog (2011) 0.92
Viral takeover of the host ubiquitin system. Front Microbiol (2011) 0.90
Functional interplay between a virus and the ESCRT machinery in archaea. Proc Natl Acad Sci U S A (2013) 0.90
Host IQGAP1 and Ebola virus VP40 interactions facilitate virus-like particle egress. J Virol (2013) 0.89
Paramyxovirus glycoprotein incorporation, assembly and budding: a three way dance for infectious particle production. Viruses (2014) 0.89
The conserved YAGL motif in human metapneumovirus is required for higher-order cellular assemblies of the matrix protein and for virion production. J Virol (2011) 0.88
Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection. J Virol (2011) 0.88
Regulation of the nucleocytoplasmic trafficking of viral and cellular proteins by ubiquitin and small ubiquitin-related modifiers. Biol Cell (2011) 0.87
The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism. J Virol (2013) 0.87
Arenavirus budding. Adv Virol (2011) 0.87
Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors. Adv Virol (2011) 0.86
RNA splicing in a new rhabdovirus from Culex mosquitoes. J Virol (2011) 0.86
The Simian virus 40 late viral protein VP4 disrupts the nuclear envelope for viral release. J Virol (2012) 0.86
Knockdown of Autophagy Inhibits Infectious Hepatitis C Virus Release by the Exosomal Pathway. J Virol (2015) 0.86
Intrinsic cytoskeleton-dependent clustering of influenza virus M2 protein with hemagglutinin assessed by FLIM-FRET. J Virol (2010) 0.85
PIV5 M protein interaction with host protein angiomotin-like 1. Virology (2009) 0.85
Cloak and Dagger: Alternative Immune Evasion and Modulation Strategies of Poxviruses. Viruses (2015) 0.84
Hendra and nipah infection: pathology, models and potential therapies. Infect Disord Drug Targets (2011) 0.84
Cellular VPS4 is required for efficient entry and egress of budded virions of Autographa californica multiple nucleopolyhedrovirus. J Virol (2011) 0.83
Multifaceted biological insights from a draft genome sequence of the tobacco hornworm moth, Manduca sexta. Insect Biochem Mol Biol (2016) 0.83
A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol (2014) 0.83
Involvement of ESCRT-II in hepatitis B virus morphogenesis. PLoS One (2014) 0.83
ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress. J Infect Dis (2015) 0.83
Liver extracellular vesicles in health and disease. J Extracell Vesicles (2012) 0.83
Arenavirus budding: a common pathway with mechanistic differences. Viruses (2013) 0.83
Molecular mechanism of arenavirus assembly and budding. Viruses (2012) 0.83
SV40 late protein VP4 forms toroidal pores to disrupt membranes for viral release. Biochemistry (2013) 0.83
Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells. PLoS Pathog (2014) 0.83
Caveolin-1 influences human influenza A virus (H1N1) multiplication in cell culture. Virol J (2010) 0.82
An integrated protein localization and interaction map for Potato yellow dwarf virus, type species of the genus Nucleorhabdovirus. Virology (2010) 0.82
Viral miniproteins. Annu Rev Microbiol (2014) 0.82
The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target. Future Virol (2015) 0.81
Parainfluenza virus 5 m protein interaction with host protein 14-3-3 negatively affects virus particle formation. J Virol (2010) 0.81
A leucine residue in the C terminus of human parainfluenza virus type 3 matrix protein is essential for efficient virus-like particle and virion release. J Virol (2014) 0.81
Foamy virus budding and release. Viruses (2013) 0.81
Basal budding and replication of the murine leukemia virus are independent of the gag L domains. J Virol (2008) 0.81
The noncanonical Gag domains p8 and n are critical for assembly and release of mouse mammary tumor virus. J Virol (2010) 0.80
Gene overlapping and size constraints in the viral world. Biol Direct (2016) 0.79
Human T-lymphotropic virus proteins and post-translational modification pathways. World J Virol (2012) 0.79
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell (2001) 12.00
Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A (1991) 10.05
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med (2001) 8.38
The protein network of HIV budding. Cell (2003) 7.82
The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function. EMBO J (1998) 7.68
Retrovirus budding. Annu Rev Cell Dev Biol (2004) 7.16
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol (1995) 6.87
AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell (2003) 6.69
Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science (2007) 6.13
The emerging shape of the ESCRT machinery. Nat Rev Mol Cell Biol (2007) 6.05
An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol (1994) 5.87
Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A (2001) 5.46
A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci U S A (2000) 5.30
The ESCRT complexes: structure and mechanism of a membrane-trafficking network. Annu Rev Biophys Biomol Struct (2006) 5.21
Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem (1999) 4.83
Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci U S A (2003) 4.21
Late budding domains and host proteins in enveloped virus release. Virology (2006) 4.11
Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol (1997) 4.08
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J Virol (1996) 3.97
A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol (1999) 3.92
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88
Aggregation and vesiculation of membrane proteins by curvature-mediated interactions. Nature (2007) 3.84
Virus maturation by budding. Microbiol Mol Biol Rev (1998) 3.78
A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release. J Virol (1998) 3.69
Mutations altering the moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle. EMBO J (1999) 3.67
Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol (2000) 3.39
Role of ESCRT-I in retroviral budding. J Virol (2003) 3.36
The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A (2003) 3.34
Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J (1997) 3.23
Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell (2007) 3.06
Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J Virol (2003) 3.05
Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci U S A (2001) 3.04
Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J Virol (2000) 2.97
Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein. J Virol (2000) 2.94
Spike protein-nucleocapsid interactions drive the budding of alphaviruses. J Virol (1992) 2.91
Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J Virol (1999) 2.90
Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci U S A (2003) 2.83
Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol (2007) 2.82
Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J Virol (2001) 2.82
Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly. J Virol (1998) 2.68
Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J Virol (2001) 2.66
Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat Struct Biol (2002) 2.66
Structural and mechanistic studies of VPS4 proteins. EMBO J (2005) 2.58
Influenza virus matrix protein is the major driving force in virus budding. J Virol (2000) 2.49
Nucleocapsid-glycoprotein interactions required for assembly of alphaviruses. J Virol (1994) 2.47
HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J Cell Biol (2004) 2.34
Foamy virus capsids require the cognate envelope protein for particle export. J Virol (1999) 2.30
Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J Virol (1996) 2.30
The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging. J Virol (2005) 2.23
Foamy virus particle formation. J Virol (1998) 2.22
Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol (2003) 2.19
The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. J Virol (2003) 2.19
Structure and ESCRT-III protein interactions of the MIT domain of human VPS4A. Proc Natl Acad Sci U S A (2005) 2.12
Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol (2003) 2.11
Cellular factors required for Lassa virus budding. J Virol (2006) 2.02
Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol (2002) 2.02
Ebola virus VP40 late domains are not essential for viral replication in cell culture. J Virol (2005) 1.97
The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding. J Biol Chem (2004) 1.92
Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol (2005) 1.88
Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins. Virology (2005) 1.85
PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected]. J Virol (2003) 1.80
Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr Top Microbiol Immunol (2004) 1.77
Structural basis for viral late-domain binding to Alix. Nat Struct Mol Biol (2007) 1.69
Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding. J Cell Sci (2004) 1.67
Membrane proteins organize a symmetrical virus. EMBO J (2000) 1.67
A concentric circle model of multivesicular body cargo sorting. EMBO Rep (2007) 1.65
Budding of PPxY-containing rhabdoviruses is not dependent on host proteins TGS101 and VPS4A. J Virol (2004) 1.64
Involvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5. J Virol (1999) 1.64
The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging. Virology (2000) 1.61
Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication. J Virol (2002) 1.60
Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly. J Virol (2005) 1.58
Role of matrix and fusion proteins in budding of Sendai virus. J Virol (2001) 1.58
Late domain-dependent inhibition of equine infectious anemia virus budding. J Virol (2004) 1.57
A dominant negative form of the AAA ATPase SKD1/VPS4 impairs membrane trafficking out of endosomal/lysosomal compartments: class E vps phenotype in mammalian cells. J Cell Sci (2003) 1.52
Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol (2006) 1.52
Mutations in the cytoplasmic tail of influenza A virus neuraminidase affect incorporation into virions. J Virol (1993) 1.51
Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5. J Virol (2002) 1.51
Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci U S A (2007) 1.49
Multivesicular bodies as a platform for formation of the Marburg virus envelope. J Virol (2004) 1.47
Tsg101 and Alix interact with murine leukemia virus Gag and cooperate with Nedd4 ubiquitin ligases during budding. J Biol Chem (2005) 1.46
The PPPY motif of human T-cell leukemia virus type 1 Gag protein is required early in the budding process. J Virol (2002) 1.45
Herpes simplex virus type 1 cytoplasmic envelopment requires functional Vps4. J Virol (2007) 1.45
AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding. J Virol (2005) 1.44
Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A. Virology (1993) 1.39
Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J Virol (2001) 1.38
Influenza virus assembly and budding at the viral budozone. Adv Virus Res (2005) 1.37
More than one door - Budding of enveloped viruses through cellular membranes. FEBS Lett (2007) 1.35
Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release. J Virol (2004) 1.34
Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology (2004) 1.34
Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies. J Virol (2007) 1.33
Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J Virol (2007) 1.32
Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101. J Virol (2006) 1.30
Role of Nedd4 and ubiquitination of Rous sarcoma virus Gag in budding of virus-like particles from cells. J Virol (2004) 1.27
Functions of early (AP-2) and late (AIP1/ALIX) endocytic proteins in equine infectious anemia virus budding. J Biol Chem (2005) 1.24
Mammalian cells express two VPS4 proteins both of which are involved in intracellular protein trafficking. J Mol Biol (2001) 1.22
The YLDL sequence within Sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J Virol (2006) 1.18
Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity. J Virol (2005) 1.18
Both the PPPY and PTAP motifs are involved in human T-cell leukemia virus type 1 particle release. J Virol (2004) 1.17
The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101. Traffic (2005) 1.16
Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature (2006) 4.44
Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell (2010) 4.33
A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A (2008) 3.99
The M2 proton channels of influenza A and B viruses. J Biol Chem (2005) 3.49
Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc Natl Acad Sci U S A (2005) 3.25
The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta. Virology (2002) 3.02
The gate of the influenza virus M2 proton channel is formed by a single tryptophan residue. J Biol Chem (2002) 3.01
Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture. J Virol (2002) 2.97
Influenza virus assembly and budding. Virology (2011) 2.90
Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci U S A (2003) 2.83
Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol (2007) 2.82
Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A (2006) 2.63
Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure (2005) 2.47
Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc Natl Acad Sci U S A (2010) 2.43
Initial structural and dynamic characterization of the M2 protein transmembrane and amphipathic helices in lipid bilayers. Protein Sci (2003) 2.43
Identification of the functional core of the influenza A virus A/M2 proton-selective ion channel. Proc Natl Acad Sci U S A (2009) 2.32
Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel. Proc Natl Acad Sci U S A (2008) 2.15
The influenza virus M2 protein cytoplasmic tail interacts with the M1 protein and influences virus assembly at the site of virus budding. J Virol (2008) 2.12
Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy. Proc Natl Acad Sci U S A (2006) 2.03
Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol (2002) 2.02
A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion. J Cell Biol (2003) 2.00
Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol (2005) 1.88
Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins. Virology (2005) 1.85
Chemical rescue of histidine selectivity filter mutants of the M2 ion channel of influenza A virus. J Biol Chem (2005) 1.78
Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc Natl Acad Sci U S A (2011) 1.77
Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes. Dev Cell (2003) 1.77
Influenza virus m2 ion channel protein is necessary for filamentous virion formation. J Virol (2010) 1.73
Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel. Biochemistry (2010) 1.73
Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly. J Virol (2005) 1.58
Controlling influenza virus replication by inhibiting its proton channel. Mol Biosyst (2006) 1.58
Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J Virol (2009) 1.56
Virology: a class act. Nature (2004) 1.54
Structure and mutagenesis of the parainfluenza virus 5 hemagglutinin-neuraminidase stalk domain reveals a four-helix bundle and the role of the stalk in fusion promotion. J Virol (2011) 1.54
Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5. J Virol (2002) 1.51
Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus. Biochemistry (2009) 1.47
Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proc Natl Acad Sci U S A (2004) 1.41
Domain architecture and oligomerization properties of the paramyxovirus PIV 5 hemagglutinin-neuraminidase (HN) protein. Virology (2008) 1.40
The interplay of functional tuning, drug resistance, and thermodynamic stability in the evolution of the M2 proton channel from the influenza A virus. Structure (2008) 1.38
Influenza virus assembly and budding at the viral budozone. Adv Virus Res (2005) 1.37
Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2. J Am Chem Soc (2011) 1.37
Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering. Proc Natl Acad Sci U S A (2012) 1.34
Influenza B virus BM2 protein is an oligomeric integral membrane protein expressed at the cell surface. Virology (2003) 1.34
Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Proc Natl Acad Sci U S A (2013) 1.34
Structure of the ulster strain newcastle disease virus hemagglutinin-neuraminidase reveals auto-inhibitory interactions associated with low virulence. PLoS Pathog (2012) 1.30
Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein. Proc Natl Acad Sci U S A (2012) 1.30
An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition. Proc Natl Acad Sci U S A (2009) 1.30
Structure of the Newcastle disease virus F protein in the post-fusion conformation. Virology (2010) 1.29
Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state. J Virol (2004) 1.24
Identification of the pore-lining residues of the BM2 ion channel protein of influenza B virus. J Biol Chem (2008) 1.20
Functional analysis of the transmembrane domain in paramyxovirus F protein-mediated membrane fusion. J Mol Biol (2008) 1.16
Influenza virus proton channels. Photochem Photobiol Sci (2006) 1.16
Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge. Virology (2007) 1.16
Expression and initial structural insights from solid-state NMR of the M2 proton channel from influenza A virus. Biochemistry (2002) 1.16
Conserved cysteine-rich domain of paramyxovirus simian virus 5 V protein plays an important role in blocking apoptosis. J Virol (2004) 1.15
Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins. Virology (2007) 1.13
Capture and imaging of a prehairpin fusion intermediate of the paramyxovirus PIV5. Proc Natl Acad Sci U S A (2011) 1.12
Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site. Nat Struct Mol Biol (2012) 1.11
Structure of the parainfluenza virus 5 (PIV5) hemagglutinin-neuraminidase (HN) ectodomain. PLoS Pathog (2013) 1.10
Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin. Virology (2011) 1.08
Mutations in the parainfluenza virus 5 fusion protein reveal domains important for fusion triggering and metastability. J Virol (2013) 1.08
Autophagy, apoptosis, and the influenza virus M2 protein. Cell Host Microbe (2009) 1.08
The oligomeric state of the active BM2 ion channel protein of influenza B virus. J Biol Chem (2007) 1.05
Fusion activation through attachment protein stalk domains indicates a conserved core mechanism of paramyxovirus entry into cells. J Virol (2014) 1.04
Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus. J Med Chem (2013) 1.03
Filamentous influenza virus enters cells via macropinocytosis. J Virol (2012) 1.02
A pH-dependent conformational ensemble mediates proton transport through the influenza A/M2 protein. Biochemistry (2010) 1.01
Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus. Virology (2011) 1.01
Exploring organosilane amines as potent inhibitors and structural probes of influenza a virus M2 proton channel. J Am Chem Soc (2011) 1.01
Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus. J Med Chem (2011) 1.00
Influenza virus budding does not require a functional AAA+ ATPase, VPS4. Virus Res (2010) 0.97
Paramyxovirus fusion: real-time measurement of parainfluenza virus 5 virus-cell fusion. Virology (2006) 0.95
The amphipathic helix of influenza A virus M2 protein is required for filamentous bud formation and scission of filamentous and spherical particles. J Virol (2013) 0.95
The paramyxovirus fusion protein C-terminal region: mutagenesis indicates an indivisible protein unit. J Virol (2011) 0.95
The influenza A virus spliced messenger RNA M mRNA3 is not required for viral replication in tissue culture. J Gen Virol (2008) 0.94
Analysis of the pH requirement for membrane fusion of different isolates of the paramyxovirus parainfluenza virus 5. J Virol (2006) 0.93
Exploring the Requirements for the Hydrophobic Scaffold and Polar Amine in inhibitors of M2 from Influenza A Virus. ACS Med Chem Lett (2011) 0.92
Viral membrane scission. Annu Rev Cell Dev Biol (2013) 0.92
Monitoring single-cell infectivity from virus-particle nanoarrays fabricated by parallel dip-pen nanolithography. Small (2007) 0.92
A role for caveolin 1 in assembly and budding of the paramyxovirus parainfluenza virus 5. J Virol (2010) 0.90
A fluorescence polarization assay using an engineered human respiratory syncytial virus F protein as a direct screening platform. Anal Biochem (2010) 0.85
Asp44 stabilizes the Trp41 gate of the M2 proton channel of influenza A virus. Structure (2013) 0.85
3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant. J Med Chem (2013) 0.85
Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel. J Am Chem Soc (2014) 0.85
Functional antibody arrays through metal ion-affinity templates. Chembiochem (2006) 0.83
Analysis of parainfluenza virus-5 hemagglutinin-neuraminidase protein mutants that are blocked in internalization and degradation. Virology (2010) 0.83
Reversible inhibition of fusion activity of a paramyxovirus fusion protein by an engineered disulfide bond in the membrane-proximal external region. J Virol (2012) 0.82
Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus. J Med Chem (2014) 0.79
Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay. PLoS One (2013) 0.78
Swine-origin influenza virus and the 2009 pandemic. Am J Respir Crit Care Med (2010) 0.78
Deadly H7N9 influenza virus: a pandemic in the making or a warning lesson? Am J Respir Crit Care Med (2013) 0.77
Viral ion channels as models for ion transport and targets for antiviral drug action. FEBS Lett (2004) 0.77
Extinct 1918 virus comes alive. Nat Med (2005) 0.76
Enhanced performance photon-counting time-of-flight sensor. Opt Express (2007) 0.75
Single-photon three-dimensional imaging at up to 10 kilometers range. Opt Express (2017) 0.75
Towards industrial ultrafast laser microwelding: SiO2 and BK7 to aluminum alloy. Appl Opt (2017) 0.75